An observational study in Periodontal Diseases, sponsored by Bulent Ecevit University. Completed. Open to participants aged 28 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-05-05.
Sponsored by Bulent Ecevit University · Observational
The purpose of this study was to evaluate acute phase proteins (APPs) Fetuin-A and Serum Amyloid A (SAA) levels in gingival crevicular fluid (GCF) and serum samples in periodontal health and disease.
The study population consisted totally 60 subjects consulted to Bulent Ecevit University, Faculty of Dentistry, Department of Periodontology whose age and sex were matched.
According to study design, subjects were divided into three groups based on their periodontal parameters. Patients suffering from chronic periodontitis formed the group 1 (n: 20), patients with plaque induced gingivitis formed the group 2 (n:20) and periodontal healthy patients were inserted in group 3 (n:20).
After gently drying the area, GCF was sampled with filter paper using the intracrevicular method (Periopaper, ProFlow, Inc., Amityville, New York, USA).Two milliliters (ml) of peripheral blood was collected from each individual with sterile syringe from the antecubital fossa by venipuncture, and to separate serum component sample centrifuged at 3000g for 5 min, and immediately stored at -40°C until assayed.
The quantity of Fetuin-A and SAA protein concentration in the samples were analyzed by sandwich enzyme-linked immunosorbent assay (ELISA) procedures using commercially available kits.
The Spearman's rank correlation test was used to detect the relationship between GCF and serum SAA and Fetuin-A with GI and CAL. All tests were performed using statistical software (SPSS Inc., version 22.0, Chicago, IL, USA). The mean ± standard deviation with mean rank values were calculated for each parameter, based on the patients as the statistical unit. P \< 0.05 was considered to be statistically significant.
855 studies on the registry are indexed under Periodontal Diseases; 189 are open to participants now.
This study's enrollment of 60 is below the median of 100 across 300 observational studies indexed under Periodontal Diseases.
Browse Periodontal Diseases studies →Bulent Ecevit University is the lead sponsor of 47 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population consisted totally 60 subjects whose age (28-45) and sex (33 men, 27 female) were matched.
Group 1 Inclusion Criteria:
Group 2 Inclusion Criteria:
Group 3 Inclusion Criteria:
Exclusion Criteria for all groups:
Chronic Periodontitis-serum amyloid A, Fetuin-A
Biological: Fetuin-A · Biological: Serum Amyloid A
Plaque induced Gingivitis-serum amyloid A, Fetuin-A
Biological: Fetuin-A · Biological: Serum Amyloid A
Control Group-serum amyloid A, Fetuin-A
Biological: Fetuin-A · Biological: Serum Amyloid A
Acute phase protein
Acute phase protein
Serum Amyloid A (SAA) levels as an inflammatory marker in periodontal disease both in serum and GCF
Time frame: Day 0
Fetuin-A levels as an inflammatory marker in periodontal disease both in serum and GCF
Time frame: Day 0
No study locations are listed for this record.
This study is completed, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bulent Ecevit University